Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer - Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer (CATS Trial) (CATS Trial)

The Tokyo cooperative oncology group0 sites600 target enrollmentApril 1, 2007

Overview

Phase: 未知
Intervention: Not specified
Conditions: Stage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
Sponsor: The Tokyo cooperative oncology group
Enrollment: 600
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

April 1, 2007

End Date

October 1, 2011

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\.With adjuvant chemotherapy 2\.History of serious drug allergy 3\.Active concomitant malignancy 4\.Serious complications 5\.Proven or suspected infections diseases 6\.Symptomatic brain metastasis 7\.Watery diarrhea or Chronic constipation 8\.Pleural effusion,peritoneal fluid,and pericardial fluid 9\.Concomitant therapy with another anticancer drug or flucytocine 10\.Pregnancy,breast feeding or wish of future bearing 11\.Mental disease or psychotic manifestation 12\.It participated in the development clinical trial of and others within 1 month 13\.Other conditions not suitable for this study